Vaccines for the New Millennium Act of 2001

The Vaccines for the New Millennium Act of 2001 proposes using the federal tax code to incentivize the private development and distribution of vaccines for global diseases such as HIV, tuberculosis, and malaria. The bill would provide tax credits to companies for the costs of medical research and for the sale of vaccines to nonprofit organizations or foreign governments for use in developing countries. Additionally, it would establish a dedicated federal fund to support the purchase of these lifesaving vaccines to ensure they reach populations in need.